You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

787 Results
Statistical Reports
Jun 2016
Statistical Reports
Jan 2018
Statistical Reports
Aug 2020
Statistical Reports
Nov 2022
Print
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Drug
Other Name(s): Columvi®
Quick Link(s): Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
High Cost Therapy Funding Program
    Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
oBINutuzumab,
glofitamab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025

Pages